The acute bacterial skin and skin structure infections (ABSSSI) market is expected to grow due to the increasing prevalence of skin infections, rising demand for effective and safe treatments, and the development of new antibiotics. The market is also driven by the growing awareness among patients and healthcare professionals about the importance of early diagnosis and treatment of skin infections. However, factors such as the emergence of antibiotic-resistant bacteria, high costs of treatment, and strict regulatory requirements may limit market growth. The ABSSSI market is highly competitive, with key players focusing on developing innovative therapies and expanding their product portfolios through partnerships and acquisitions. Additionally, the COVID-19 pandemic has impacted the market, with delays in clinical trials and disruptions to supply chains affecting the development and availability of new treatments.
The global Acute Bacterial Skin And Skin Structure Infections Market is estimated to be valued at US$ 3,466.6 Mn in 2022 and is expected to exhibit a CAGR of 6.0% over the forecast period (2022-2030)
Top Companies in the Acute Bacterial Skin And Skin Structure Infections Industry:
1. Fresenius SE & Co. KGaA
Founded in 1912, Fresenius is a global healthcare company headquartered in Bad Homburg, Germany. It operates in more than 100 countries and is focused on providing products and services for dialysis, hospitals, and other medical care facilities.
2. Pfizer, Inc.
Established in 1849, Pfizer is an American multinational pharmaceutical corporation headquartered in New York City. The company operates in over 175 countries and is focused on researching, developing, and producing medicines and vaccines to help improve health outcomes for people around the world. In January, 2023 Gero announced that it has entered into a research collaboration with Pfizer to apply Gero’s machine learning technology platform to discover potential therapeutic targets for fibrotic diseases using large-scale human-based data.
3. Amneal Pharmaceuticals LLC
Founded in 2002, Amneal Pharmaceuticals is a generic drug manufacturer headquartered in Bridgewater, New Jersey. The company operates in over 150 countries and is focused on providing affordable, high-quality medications to patients. In January, 2023 Amneal Pharmaceuticals, Inc. announced it has signed a long-term license agreement with Orion Corporation to commercialize a number of Amneal’s complex generic products.
4. Intas Pharmaceuticals Ltd.
Established in 1984, Intas Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. The company operates in over 85 countries and is focused on developing and producing affordable medicines in various therapeutic areas.
5. Cadila Healthcare Ltd.
Founded in 1952, Cadila Healthcare is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. The company operates in over 90 countries and is focused on developing and producing medicines in various therapeutic areas, including cardiovascular, oncology, and gastrointestinal.
6. Glenmark Pharmaceuticals Ltd
Established in 1977, Glenmark Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company operates in over 80 countries and is focused on developing and producing medicines in various therapeutic areas, including respiratory, dermatology, and oncology. In March, 2023 Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceuticals company has received final approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%|0.064%, the generic version of Enstilar®1 Foam, 0.005%|0.064%, of Leo Pharma AS.
7. GlaxoSmithKline plc.
Founded in 2000, GlaxoSmithKline is a British multinational pharmaceutical company headquartered in Brentford, London. The company operates in over 150 countries and is focused on researching, developing, and producing medicines and vaccines to help improve health outcomes for people around the world.
8. Sun Pharmaceutical Industries Ltd.
Established in 1983, Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company operates in over 100 countries and is focused on developing and producing medicines in various therapeutic areas, including psychiatry, neurology, and cardiology.
9. Sandoz Inc.
Founded in 1886, Sandoz is a Swiss multinational pharmaceutical company headquartered in Holzkirchen, Switzerland. The company operates in over 160 countries and is focused on developing and producing generic and biosimilar medicines to help improve access to affordable healthcare around the world.
10. Aurobindo Pharma Ltd.
Established in 1986, Aurobindo Pharma is an Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana. The company operates in over 150 countries and is focused on developing and producing generic and branded medicines in various therapeutic areas.
11. AbbVie, Inc.
Founded in 2013, AbbVie is an American multinational pharmaceutical company headquartered in North Chicago, Illinois. The company operates in over 175 countries and is focused on researching, developing, and producing medicines and therapies in various therapeutic areas, including immunology, oncology, and neuroscience.
12. Melinta Therapeutics, Inc.
Established in 2000, Melinta Therapeutics is an American pharmaceutical company headquartered in Morristown, New Jersey. The company operates in over 40 countries and is focused on developing and producing antibiotics and other therapeutics to help address the growing problem of antibiotic resistance.
13. Accord Healthcare Ltd.
Founded in 2008, Accord Healthcare is a British multinational pharmaceutical company headquartered in London, UK. The company operates in over 50 countries and is focused on developing and producing generic and biosimilar medicines in various therapeutic
*Definition- Acute bacterial skin and skin structure infections (ABSSSI) refer to bacterial infections that affect the skin and underlying tissue, including cellulitis, abscesses, and wound infections. These infections are caused by a range of bacteria and can lead to serious complications if left untreated.
